Correlation Between Novartis and Daiichi Sankyo
Can any of the company-specific risk be diversified away by investing in both Novartis and Daiichi Sankyo at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novartis and Daiichi Sankyo into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novartis AG ADR and Daiichi Sankyo Co, you can compare the effects of market volatilities on Novartis and Daiichi Sankyo and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novartis with a short position of Daiichi Sankyo. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novartis and Daiichi Sankyo.
Diversification Opportunities for Novartis and Daiichi Sankyo
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Novartis and Daiichi is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Novartis AG ADR and Daiichi Sankyo Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Daiichi Sankyo and Novartis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novartis AG ADR are associated (or correlated) with Daiichi Sankyo. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Daiichi Sankyo has no effect on the direction of Novartis i.e., Novartis and Daiichi Sankyo go up and down completely randomly.
Pair Corralation between Novartis and Daiichi Sankyo
Considering the 90-day investment horizon Novartis AG ADR is expected to under-perform the Daiichi Sankyo. But the stock apears to be less risky and, when comparing its historical volatility, Novartis AG ADR is 2.15 times less risky than Daiichi Sankyo. The stock trades about -0.28 of its potential returns per unit of risk. The Daiichi Sankyo Co is currently generating about -0.12 of returns per unit of risk over similar time horizon. If you would invest 3,226 in Daiichi Sankyo Co on August 30, 2024 and sell it today you would lose (168.00) from holding Daiichi Sankyo Co or give up 5.21% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Novartis AG ADR vs. Daiichi Sankyo Co
Performance |
| Timeline |
| Novartis AG ADR |
| Daiichi Sankyo |
Novartis and Daiichi Sankyo Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novartis and Daiichi Sankyo
The main advantage of trading using opposite Novartis and Daiichi Sankyo positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novartis position performs unexpectedly, Daiichi Sankyo can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Daiichi Sankyo will offset losses from the drop in Daiichi Sankyo's long position.| Novartis vs. AstraZeneca PLC ADR | Novartis vs. GlaxoSmithKline PLC ADR | Novartis vs. Roche Holding Ltd | Novartis vs. Bristol Myers Squibb |
| Daiichi Sankyo vs. Astellas Pharma | Daiichi Sankyo vs. Grifols SA ADR | Daiichi Sankyo vs. Roche Holding Ltd | Daiichi Sankyo vs. Novartis AG ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |